Financials in USD. Standardized financial statements.
A compact view of how Brain Scientific Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $214,564 | $265,747 | $93,664 | $489,202 | $58,113 | $7,022 | $0 | $0 |
| Revenue Growth? | -19.3% | +183.7% | -80.9% | +741.8% | +727.6% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $160,239 | $182,519 | $43,762 | $387,194 | $33,939 | $445 | $0 | $0 |
| Gross Profit? | $54,325 | $83,228 | $49,902 | $102,008 | $24,174 | $6,577 | $0 | $0 |
| Gross Margin? | +25.3% | +31.3% | +53.3% | +20.9% | +41.6% | +93.7% | 0.0% | 0.0% |
| Operating Expenses? | $9.66M | $8.74M | $2.82M | $1.07M | $1.31M | $904,755 | $90,495 | $50 |
| Operating Income? | -$9.61M | -$8.66M | -$2.77M | -$970,190 | -$1.29M | -$905,200 | -$90,500 | -$50 |
| EBITDA? | -$7.93M | -$8.32M | -$2.75M | -$968,858 | -$1.28M | -$904,755 | $0 | -$50 |
| Income Before Tax | -$12.34M | -$9.10M | -$2.80M | -$1.00M | -$1.43M | -$958,282 | -$90,733 | -$50 |
| Income Tax Expense | $0 | $0 | $0 | $2,214 | $0 | -$5 | $0 | $0 |
| Net Income? | -$12.34M | -$9.10M | -$2.80M | -$1.00M | -$1.43M | -$958,282 | -$90,733 | -$50 |
| EPS? | $-12.95 | $-25.21 | $-8.88 | $-4.44 | $-9.72 | $-6.65 | $-0.78 | $-0.00 |
| Diluted EPS? | $-12.95 | $-25.21 | $-8.88 | $-4.44 | $-9.72 | $-6.65 | $-0.78 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality